Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer. [electronic resource] by
- Raza, Umar
- Saatci, Özge
- Uhlmann, Stefan
- Ansari, Suhail A
- Eyüpoğlu, Erol
- Yurdusev, Emre
- Mutlu, Merve
- Ersan, Pelin Gülizar
- Altundağ, Mustafa Kadri
- Zhang, Jitao David
- Doğan, Hayriye Tatlı
- Güler, Gülnur
- Şahin, Özgür
Producer: 20180223
In:
Oncotarget vol. 7
Availability: No items available.
|
|
8.
|
Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer. [electronic resource] by
- Mishra, Rasmi R
- Belder, Nevin
- Ansari, Suhail A
- Kayhan, Merve
- Bal, Hilal
- Raza, Umar
- Ersan, Pelin G
- Tokat, Ünal M
- Eyüpoğlu, Erol
- Saatci, Özge
- Jandaghi, Pouria
- Wiemann, Stefan
- Üner, Ayşegül
- Cekic, Caglar
- Riazalhosseini, Yasser
- Şahin, Özgür
Producer: 20191218
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24
Availability: No items available.
|